TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · major macro event coming up
SLN

Silence Therapeutics PLC

Healthcare · Biotechnology

10.70$ -2.0% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SLN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – -724.0% – -721.0% – – –
– -45.2% +70.3% +39.7% -7.9% +20.8% +2.9% +16.2% +3.4% -16.4% -4.8% +17.1%
– -31.1% -38.9% +34.3% +6.7% -14.2% +652.6% +165.1% +8.9% +2.9% -20.2% -22.4%
– – – – – -176.1% – -7.2% -59.5% – – –
– – – – -135.1% – -11.5% +181.0% -137.0% – – –
– +151.5% -36.8% -67.8% +8.7% -95.2% +5,611.1% +250.3% -69.7% -91.7% +274.7% -67.4%
– – -208.1% – -137.1% +210.9% – +21.7% -275.1% – -206.8% +173.4%
– – – -100.0% – – – – – – – –
– – – – +0.0% +0.0% +0.0% -47.5% -10.0% +16.7% – –
– +261.1% -100.3% – +610.4% +1,446.3% +192.6% +168.7% +26.9% -52.2% +351.4% -100.0%
– +3,524.6% -136.8% – -669.3% – – +346.4% -153.2% – – -362.1%
– – – – – – -757.2% – -879.8% – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?